Tagged with Valneva

European Biotech Roundup: BioNTech & CureVac Deal to Boost German Vaccine Capacity; Valneva’s Scottish Manufacturing Plans; Morphosys Consolidates German R&D

Europe European Biotech Roundup: BioNTech & CureVac Deal to Boost German Vaccine Capacity; Valneva’s Scottish Manufacturing Plans; Morphosys Consolidates German R&D

Europe A roundup of the latest news from European biotech, including BioNTech and CureVac’s German vaccine manufacturing deal; the revival of Valneva’s plans to manufacture its vaccine in Scotland; and Morphosys’ shuttering of its US R&D footprint. BioNTech, CureVac part of $3.14B deal to bolster German vaccine capacity through 2029:…

France Pharma News: Germany Production Alliance Falters; Sanofi Vaccine Enters Phase III Trials; Valneva Still in the Vaccine Race

France France Pharma News: Germany Production Alliance Falters; Sanofi Vaccine Enters Phase III Trials; Valneva Still in the Vaccine Race

France The latest news from French pharma, including why President Emmanuel Macron’s initiative to bring medical production back to Europe has hit a wall, Sanofi’s slow progress towards finally bringing its COVID-19 vaccine candidate to market, and why investors are still betting on Valneva. Macron’s Push for German Pharma Alliance…

Valneva: A COVID-19 Vaccine Success Story for France?

France Valneva: A COVID-19 Vaccine Success Story for France?

France While Big Pharma companies like Pfizer, Janssen and AstraZeneca, have grabbed the headlines over the past year for their work on COVID-19 vaccines, smaller and lesser-known companies are also playing a crucial role in the development of both large companies’ candidates and their own self-developed shots. At the onset…

Janet Hoogstraate – Chair of the Management Board, Valneva Sweden

Sweden Janet Hoogstraate – Chair of the Management Board, Valneva Sweden

Sweden Infectious diseases kill over 17 million people each year, according to the WHO, which is why vaccine-specialist Valneva is continuing to grow and develop the next generation of vaccines. Janet Hoogstraate, chair of the Management Board of Valneva Sweden, explains the high-quality of their manufacturing operations in the country and…

Canada: Smaller Market Entrants with Big Plans

Canada Canada: Smaller Market Entrants with Big Plans

Canada Several smaller pharmaceutical companies – Taiho, Valneva, Mallinckrodt, Théa and Intercept Pharma – have chosen to set up operations in Canada very recently, recognizing the potential for product launches and development or taking back their out-licensed portfolio. “The establishment of the Canadian affiliate had always been part of our global expansion…

Interview: Greig Estabrooks – General Manager, Valneva Canada

Canada Interview: Greig Estabrooks – General Manager, Valneva Canada

Canada Greig Estabrooks, general manager of Valneva, talks partnership opportunities for the French-Austrian pure-play vaccine company in Canada, its exciting pipeline, and how he encourages his global R&D colleagues to consider conducting clinical trials for their pipeline products in Canada in order to leverage the country’s great infrastructure and significant human…

Other Topics

India

M&A

European Biotech

Cell & Gene Therapy

R&D Section Page